HuCoCSys
Description
Early detection of negative effects of immunotherapeutic drug substances using innovative, highly complex, human organotypical co-culture systems combined with systems biology-based signaling pathway analysis
Partner:
- EDI GMBH
- InterMed Discovery GmbH
- MERCK KgGA
- University Hospital Ulm, Experimental Anaesthesiology
Projectlead
Dr. rer. nat. Thomas Joos
Deputy Director of the Institute
NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de
Follow us now
